Dana–Farber Cancer Institute is a comprehensive cancer treatment and research center in Boston, Massachusetts
The Latest Bing News on:
Dana-Farber Cancer Institute Research
- New Potential Target for Leukemia Therapy Identified
A team of Dana-Farber Cancer Institute investigators discovered that a subset of myeloid and lymphoid leukemias depend on a molecular complex called PI3Kgamma for survival.
- James Rosatto Walk on Water Benefitting Dana-Faber Cancer Institute Set for June 8
If you missed last year, don’t worry, you can walk this year. Please join, Saturday, June 8th 2024, at the Eliot Circle end of Revere Beach for our 3rd annual James Rosatto Walk on Water benefitting ...
- Using AI Tools To Improve Research Integrity Processes
The first misconduct allegations publicized in 2024 were reported in a research integrity blog by biologist Sholto Davi. 1 The blog questions images in 57 papers authored by four top researchers at ...
- New target for potential leukemia therapy
Boston -- A team of Dana-Farber Cancer Institute investigators discovered that a subset ... Rather than focusing on mutations, first author Qingyu Luo, MD, PhD, a research fellow in Lane's lab, used ...
- Dana-Farber researchers discover new target for potential leukemia therapy
A team of Dana-Farber Cancer Institute investigators discovered that a subset of myeloid and lymphoid leukemias depend on a molecular complex called PI3Kgamma for survival. The study provides both ...
The Latest Bing News on:
Dana-Farber Cancer Institute Discovery
- James Rosatto Walk on Water Benefitting Dana-Faber Cancer Institute Set for June 8
If you missed last year, don’t worry, you can walk this year. Please join, Saturday, June 8th 2024, at the Eliot Circle end of Revere Beach for our 3rd annual James Rosatto Walk on Water benefitting ...
- LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activation in Cancer”
Recent Findings Relate to LIXTE’s Lead Clinical Compound, LB-100, to be Presented at Workshop on May 9 and 10 at Harvard’s Dana Farber Cancer Institute in Boston PASADENA ... in the scientific journal ...
- Dana-Farber researchers discover new target for potential leukemia therapy
A team of Dana-Farber Cancer Institute investigators discovered that a subset of myeloid and lymphoid leukemias depend on a molecular complex called PI3Kgamma for survival. The study provides both ...
- Advancing equity in cancer care: Lessons from NCI-DCCs' community outreach and engagement initiatives
Investigators at Dana-Farber Cancer Institute have examined the historical evolution of Community Outreach and Engagement initiatives at both the National Cancer Institute (NCI) and National Cancer ...
- New research examines past and guides future efforts to reduce cancer disparities
Investigators at Dana-Farber Cancer Institute have examined the historical evolution of Community Outreach and Engagement initiatives at both the National Cancer Institute (NCI) and National Cancer ...